Australia has several real-world evidence (RWE) initiatives to support healthcare and drug development. The Therapeutic Goods Administration (TGA) has established a framework for the use of real-world data (RWD) and RWE in regulatory decision-making, which includes the use of data from electronic health records and disease registries [1]. Following the 2021 Review into the usage of RWE and patient-reported outcomes (PROs) in the regulation of medicines and medical devices, the TGA has been working on incorporating RWE and PROs into its regulatory processes [2][3][4].
Additionally, the Medicines Intelligence Centre of Research Excellence (MI-CRE) was established to generate timely research supporting the evidentiary needs of Australian medicines regulators and payers by accelerating the development and translation of RWE on medicines use and outcomes [4]. MI-CRE aims to equip the next generation of medicines researchers in Australia with the skills to co-create evidence with end-users [5].
Despite these initiatives, there are still challenges and gaps in Australia’s RWE landscape. A review on generating RWE on the quality use, benefits, and safety of medicines in Australia highlights the need for a roadmap to bolster Australia’s capacity to accelerate evidence development about the effectiveness, safety, and quality use of medicines in routine clinical care [6]. Robust RWE generation requires current data roadblocks to be remedied as a matter of urgency to deliver efficient and equitable healthcare and improve the health and well-being of all Australians [6].
References:
[1] https://globalforum.diaglobal.org/issue/may-2023/rwd-rwe-in-2023-regulatory-policy-world-tour/
[2] https://www.tga.gov.au/real-world-evidence-rwe-and-patient-reported-outcomes-pros
[4] https://www.sciencedirect.com/science/article/pii/S0149291822000170
[5] https://ijpds.org/article/view/1726
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707536/
Share this story...
EU – EMA RWE Framework to Support Regulatory Decision Making
RWE 201 - EU – EMA RWE Framework to Support Regulatory Decision Making EMA RWE Framework 2023: https://www.ema.europa.eu/en/documents/report/real-world-evidence-framework-support-eu-regulatory-decision-making-report-experience-gained_en.pdfThe European Medicine Agency (EMA) is actively working on creating a framework [...]
EU – EMA’s 2025 Vision for RWE
RWE 201 - EU – EMA’s 2025 Vision for RWE EMA 2025 Vision: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299492/ EMA RWE Framework Report: https://www.ema.europa.eu/en/documents/report/real-world-evidence-framework-support-eu-regulatory-decision-making-report-experience-gained_en.pdf The European Medicines Agency (EMA) isn't simply relying [...]
EU – The Data Governance Act
RWE 201 - EU – The Data Governance Act Data Governance Act: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0868The EU Data Governance Act (DGA) aims to establish a legal framework for data sharing across sectors. [...]
EU – The European Health Data Space
RWE 201 - EU - The European Health Data Space [Image Source: https://tehdas.eu/results/tehdas-identifies-user-journey-for-cross-border-health-data-sharing/]EHDS: https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space_enThe European Health Data Space (EHDS) is an initiative by the European Commission to foster the [...]
EU – EU4Health Program
RWE 201 - EU - EU4Health Program EU4Health: https://health.ec.europa.eu/funding/eu4health-programme-2021-2027-vision-healthier-european-union_enEU4Health is an ambitious EU health program for the years 2021-2027. Its primary goal is to bolster the resilience of Europe's [...]
EU 2021 – Setting the Scene for the European Health Data Space
RWE 201 - EU 2021 – Setting the Scene for the European Health Data Space Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.CI.2021.269.01.0003.01.ENGIn the evolving healthcare framework of the European Union (EU), the prominence of [...]







